• Olaparib Beneficial for BRCA-Mutated HER2-Negative Breast Cancer

    6 days ago - By Medscape

    Dr Kathy Miller shares the 'biggest news in the breast cancer world' from ASCO, with presented data showing the benefit of olaparib in patients with high-risk, BRCA -mutated HER2-negative disease.
    Medscape Oncology
    Read more ...